Targeting Alternative T cell Effector Pathways to Enhance the Activity of CD3-Engaging Bispecific Antibodies
Time: 2:00 pm
day: Conference Day 2
Details:
- Regeneron’s approach to improving cytotoxic T cell activity by adding co-stimulatory targeted biologics
- Examples from hematological and solid tumors
- Exploring what are the optimal co-stimulatory agents to activate T cells in combination with CD3 bispecifics?
